Eric Tardif
Gründer bei Maravai Life Sciences, Inc.
Aktive Positionen von Eric Tardif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Gründer | 18.03.2014 | - |
Unternehmenssekretär | - | - | |
Corporate Officer/Principal | 18.03.2014 | - | |
Präsident | 18.03.2014 | - | |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Präsident | - | - |
Karriereverlauf von Eric Tardif
Ehemalige bekannte Positionen von Eric Tardif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MARAVAI LIFESCIENCES HOLDINGS, INC. | Gründer | 01.03.2014 | 30.06.2021 |
Präsident | 01.03.2014 | 30.06.2021 | |
HOLOGIC, INC. | Corporate Officer/Principal | - | - |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 13.01.2009 | 18.10.2011 |
Vertrieb & Marketing | 18.10.2011 | - |
Ausbildung von Eric Tardif
Bishop's University | Undergraduate Degree |
University of British Columbia | Masters Business Admin |
Boston College | Graduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Kanada | 3 |
Operativ
President | 3 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 4 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
HOLOGIC, INC. | Health Technology |
MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
Vector Laboratories, Inc.
Vector Laboratories, Inc. Chemicals: Major DiversifiedProcess Industries Vector Laboratories, Inc. develops, manufactures and markets labeling and detection reagents for immunohistochemistry, immunofluorescence, DNA/RNA and glycobiology. Its products include neuronal tracers, ultrapure immunological products, and novel reagents for detection and isolation of nucleic acids, fusion proteins and carbohydrates. The company was founded in 1976 and is headquartered in Burlingame, CA. | Process Industries |
- Börse
- Insiders
- Eric Tardif
- Erfahrung